Sloan-Kettering Institute for Cancer Research — New York, New York

Sloan-Kettering Institute for Cancer Research is a clinical research site located in New York, New York, United States.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

Sloan-Kettering Institute for Cancer Research has participated in 2 clinical trials.

Therapeutic areas: Glioblastoma Multiforme, Bone Marrow Transplantation, Blood Disease.

Sponsors: Thallion Pharmaceuticals, National Heart, Lung, and Blood Institute (NHLBI).

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sloan-Kettering Institute for Cancer Research?

Sloan-Kettering Institute for Cancer Research has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sloan-Kettering Institute for Cancer Research conducted?

Sloan-Kettering Institute for Cancer Research has 2 clinical trials on record. Their work covers Glioblastoma Multiforme, Bone Marrow Transplantation, Blood Disease.

Is Sloan-Kettering Institute for Cancer Research accredited by Crixeo Health?

Sloan-Kettering Institute for Cancer Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sloan-Kettering Institute for Cancer Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.